In today's trading, Knight Therapeutics Inc shares closed at $5.79 after opening the day at $5.66. prices ranged from a low of $5.66 to a high of $5.81.

Shares boosted 1.05% from the previous day's close of $5.73.

During the day across North America, the TSX Composite closed 0.19% at 22011.62, the S&P 500 closed 1.02% at 5099.96, the Dow Jones Industrial Average closed 0.40% at 38239.66 and the Nasdaq Composite closed 2.03% at 15927.90.

Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).

Trading volume was 25,091 on 126 total trades, while having an average volume of 34,768 over the last 5-days.

The TSX overall saw 3,150 price advancers against 2,056 declines and 108 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.95 (April 11,2024) and low as $4.35 (October 23,2023). Moreover, in the last 12 months, Knight Therapeutics Inc's shares have boosted 28.67 percent, while they have gained 11.56% since the start of 2024.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $579.71 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Based on 4.00 analysts, Knight Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..